Shares of Natco Pharma on Wednesday dropped over 3 per cent after the company reported 35 per cent decline in consolidated net profit for the quarter ended September 30, 2019.
The scrip fell 3.39 per cent to close at Rs 560.80 on the BSE. During the day, it tumbled 6.71 per cent to Rs 541.50.
On the NSE, it declined 3.20 per cent to close at Rs 560.05.
Natco Pharma on Tuesday reported 35 per cent decline in consolidated net profit at Rs 117.7 crore for the quarter ended September 30, 2019.
The Hyderabad-based company had posted a profit of Rs 181.1 crore in the year-ago period.
Total income stood at Rs 518.9 crore for the quarter under review as against Rs 583.5 crore in the year-ago period, a decline of 11 per cent, Natco Pharma said in a BSE filing.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app